Recruiting NA INTERVENTIONAL 1-arm NCT06157437

An Exploratory Study of Focal Pulse Ablation System in the Treatment of Atrial Arrhythmia

Sponsor: Hangzhou Dinova EP Technology Co., Ltd

Conditions Atrial Fibrillation (AF) Typical Atrial Flutter

Interventions Focal Pulse field Ablation

Updated 4 times since 2024 Last updated: Feb 7, 2025 Started: Dec 1, 2023 Primary completion: Jun 30, 2025 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Atrial Fibrillation (AF) and Typical Atrial Flutter and is currently actively recruiting participants. Hangzhou Dinova EP Technology Co., Ltd leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Mar 2025 — Present [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Mar 2025 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Dec 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hangzhou Dinova EP Technology Co., Ltd

Data source: Hangzhou Dinova EP Technology Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China